Chinese herb formulas with "yiqi jianpi jiedu huayu" can effectively treat hepatocellular carcinoma, but the mechanisms are unknown. Understanding this can improve HCC treatment with traditional Chinese medicine.
Researchers screened plant extracts for anti-metastatic properties in breast cancer cells by targeting CD82 expression. Results show potential for multi-system treatment to inhibit metastasis and improve patient outcomes.
Fig latex encapsulated in CA/PEO nanofiber scaffold effectively targets cancer cells with minimal harm to normal cells, demonstrating promising potential as a safer alternative to traditional chemotherapy.
GPG, a glucan from Ganoderma lucidum, improves immune response in breast cancer. Combining with Gemcitabine reduces tumor burden, alters TME, and inhibits MDSC expansion. GPG reverses immunosuppression induced by chemotherapy.
Researchers evaluated Solanum virginianum seeds for therapeutic compounds. Methanol extract showed highest phenolic & flavonoid content, antioxidant activity, and promising anticancer potential. This study emphasizes the importance of natural compounds in drug discovery.
Scientists studied plants from the Phyllanthus genus for potential cancer treatments. They identified bioactive compounds using advanced analytical techniques and found promising results, suggesting the potential for future drug development. This research highlights the importance of natural products in cancer therapy.
"SBT-B from S. barbata inhibits P-gp, reversing MDR in breast cancer. Identified 18 novel metabolites, mainly through oxidization and acetylation. Targets p27 phosphorylation, p53 signaling, and inhibits P-gp expression. Provides new insight for P-gp inhibitor development."